Back to Newsroom

Novavax to Host 4th Annual Investor and Analyst Meeting

GAITHERSBURG, Md., Sept. 07, 2016 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) today announced it will host its 4th annual Investor and Analyst Meeting, Tuesday, October 11, 2016 from 9:00 a.m. – 11:00 a.m. ET in New York, NY.

Senior management will conduct a series of presentations to update analysts and investors on the Company’s ongoing clinical development programs. In addition, a key opinion leader will provide a clinical perspective on respiratory syncytial virus (RSV) disease.

Novavax expects to announce data from its pivotal Phase 3 trial of the RSV F Vaccine in older adults in the third quarter of 2016.

For additional information and registration, please email or call 443-213-0506.

Click here to read the full release